Domingo A Pascual-Figal
Overview
Explore the profile of Domingo A Pascual-Figal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1958
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fiolet A, Poorthuis M, Opstal T, Amarenco P, Boczar K, Buysschaert I, et al.
EClinicalMedicine
. 2024 Oct;
76:102835.
PMID: 39431112
Background: Guidelines recommend low-dose colchicine for secondary prevention in cardiovascular disease, but uncertainty remains concerning its efficacy for stroke, efficacy in key subgroups and about uncommon but serious safety outcomes....
2.
Remior-Perez P, Gomez-Molina M, Garcia-Rodriguez D, Gallego-Delgado M, Mohamed-Salem L, de Haro-Del Moral J, et al.
Can J Cardiol
. 2024 Oct;
41(2):167-177.
PMID: 39424187
Background: Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly recognized as a treatable form of heart failure. Atrial fibrillation (AF) is common in patients with ATTR-CA. Whether recent-onset AF can be used...
3.
Pastor-Perez F, Garrido-Bravo I, Penafiel-Verdu P, Fernandez-Villa N, Manzano-Fernandez S, Oliva-Sandoval M, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 May;
77(10):851-858.
PMID: 38701881
Introduction And Objectives: Cardiac resynchronization therapy (CRT) is an effective treatment for patients with nonischemic dilated cardiomyopathy associated with left bundle branch block (LBBB). In these patients, the device can...
4.
Wade U, Pascual-Figal D, Rabbani F, Ernst M, Albert A, Janssens I, et al.
Nutrients
. 2024 Apr;
16(8).
PMID: 38674895
Irritable bowel syndrome (IBS) is a prevalent chronic functional gastrointestinal disorder, characterised by recurrent abdominal discomfort and altered bowel movements. IBS cause a significantly negative impact on quality of life...
5.
Pascual-Figal D, Hernandez-Vicente A, Pastor-Perez F, Martinez-Selles M, Sole-Gonzalez E, Alvarez-Garcia J, et al.
Eur J Heart Fail
. 2024 Apr;
26(4):776-784.
PMID: 38606524
Aims: There is a lack of specific studies assessing the impact of natriuretic peptide monitoring in the post-discharge management of patients with heart failure (HF) and preserved ejection fraction (HFpEF),...
6.
Pascual-Figal D, Zamorano J, Domingo M, Morillas H, Nunez J, Marcos M, et al.
Eur J Heart Fail
. 2023 May;
25(8):1352-1360.
PMID: 37211950
Aims: Dapagliflozin improves the prognosis of patients with heart failure (HF), regardless of left ventricular ejection fraction (LVEF). However, its effect on cardiac remodelling parameters, specifically left atrial (LA) remodelling,...
7.
McEwan P, Harrison C, Binnie R, Lewis R, Cohen-Solal A, Lund L, et al.
Eur J Heart Fail
. 2023 Jan;
25(3):389-398.
PMID: 36718652
Aims: Iron deficiency (ID) is comorbid in up to 50% patients with heart failure (HF) and exacerbates disease burden. Ferric carboxymaltose (FCM) reduced HF hospitalizations and improved quality of life...
8.
Diez-Diez M, Amoros-Perez M, de la Barrera J, Vazquez E, Quintas A, Pascual-Figal D, et al.
Geroscience
. 2022 Jun;
45(2):1231-1236.
PMID: 35752705
Clonal hematopoiesis of indeterminate potential (CHIP), defined as the presence of somatic mutations in cancer-related genes in blood cells in the absence of hematological cancer, has recently emerged as an...
9.
Khan A, Iqtadar S, Mumtaz S, Heinrich M, Pascual-Figal D, Livingstone S, et al.
Front Pharmacol
. 2022 Jun;
13:898062.
PMID: 35747751
Curcumin, quercetin, and vitamin D3 (cholecalciferol) are common natural ingredients of human nutrition and reportedly exhibit promising anti-inflammatory, immunomodulatory, broad-spectrum antiviral, and antioxidant activities. The present study aimed to investigate...
10.
Codina P, Domingo M, Barcelo E, Gastelurrutia P, Casquete D, Vila J, et al.
ESC Heart Fail
. 2022 May;
9(4):2170-2180.
PMID: 35588235
Aims: Prior studies have not fully characterized the haemodynamic effects of the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan in heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF-PH). The aim...